Literature DB >> 29542290

Osimertinib for an older de novo T790M patient with chronic kidney disease.

Hideyasu Yamada1,2,3, Hiroaki Satoh2,4, Norihito Hida3, Taisuke Nakaizumi3, Hideo Terashima1, Nobuyuki Hizawa4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29542290     DOI： 10.1111/ggi.13230

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN： 1447-0594            Impact factor:   2.730


× No keyword cloud information.
  2 in total

Review 1.  Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure.

Authors:  Kenichi Fujita; Natsumi Matsumoto; Hiroo Ishida; Yutaro Kubota; Shinichi Iwai; Motoko Shibanuma; Yukio Kato
Journal:  Curr Drug Metab       Date:  2019       Impact factor: 3.731

2.  Long-term response to osimertinib in elderly patients with lung adenocarcinoma harbouring de novo EGFR T790M: a case report and literature review.

Authors:  Toshiyuki Sumi; Koki Kamada; Naoki Shijubou; Yuichi Yamada; Hisashi Nakata; Yuji Mori; Hirofumi Chiba
Journal:  Respirol Case Rep       Date:  2021-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.